CalPERS Selects CVS Caremark as PBM, Replacing OptumRx
CalPERS has entered into a five-year agreement with CVS Caremark, who will provide outpatient prescription drug benefits for about 587,000 members enrolled in basic or Medicare HMO or PPO plans.
AstraZeneca Blockbuster Prospect Is a Bust in Pivotal Test in Light Chain Amyloidosis
Though anselamimab failed its Phase 3 test in light chain amyloidosis, AstraZeneca points to encouraging results in a pre-defined patient subgroup — which may not be a winning strategy. Prothena resurrected its failed drug candidate for the disease based on a subgroup analysis, only to see that antibody fall short in a pivotal study.
The Human Algorithm: What AI Can’t Replace in Pharma Engagement
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.
The Crisis That Unites Us: Healthcare Costs Are Breaking Everyone
The transformation of our healthcare system can start now, with employers adopting value-based care models, communities demanding better access, and policymakers challenging the status quo.
Men’s Health is an Overlooked Part of Family Health: Why Employers Should Rethink Their Benefits Strategy
This is more than a missed opportunity. It’s a growing liability financially, operationally, and culturally. Men’s health must be redefined not just as a clinical issue, but as a strategic business lever.
Using Case Management to Improve Maternal Health Outcomes
A new report from ProgenyHealth highlights the importance of taking a multipronged approach to identifying and managing risk factors for maternal health and taking steps to reduce the risks of premature births.
Report: Majority of Medicare Advantage Markets Lack Competition
A recent KFF report showed that in 2024, 79% of counties in the U.S. were highly concentrated for Medicare Advantage, and 18% were very highly concentrated.
What Are Healthcare Organizations Getting Wrong about Email Security?
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.
How Allina Health Is Modernizing Its Supply Chain Strategy
As hospitals face ongoing cost pressures and supply chain disruptions, Allina Health is redesigning its procurement strategy by moving away from a decentralized sourcing model and toward an approach that prioritizes governance and tech-driven efficiencies. Chief Supply Chain Officer Tom Lubotsky shared how the health system is saving money and boosting supply chain resilience.
No More Band-Aids: Hiring Isn’t the Answer to Burnout
Clinicians drop off early in the pipeline because they receive little context and minimal support. The only way to solve this problem is to create a system that drives long-term retention and workforce stability by supporting clinician well-being.
Generation Generative: What Healthcare Marketers Need To Know About Generative AI
If you want your company’s website to pop up on the right side of an AI-generated response, it’s crucial to build rich, authoritative content so that AI crawlers find your site and use your information to generate these overviews, leading patients to your digital front door. Here are some practical ways to do that.
New Bipartisan Bill from Rep. Carter Aims to Crack Down on PBMs
A bill introduced by Rep. Earl L. "Buddy" Carter would ban PBMs’ use of spread pricing in Medicaid, among other reforms.
presented by
The Top 5 Home Care Franchise Opportunities in the U.S.
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.
Bayer’s Blockbuster Hopeful Kerendia Expands its FDA Approval to Type of Heart Failure
The FDA approved Bayer’s Kerendia for reducing the risk of heart failure in patients with mildly reduced ejection fraction, a measure of how much blood the organ can pump. The daily pill was first approved in 2021 for patients with chronic kidney disease associated with type 2 diabetes.
Behavioral Health Has A Data Problem. Health Plans Are Sitting On The Solution
It’s not that the data isn’t there. We have years of claims, pharmacy, and clinical data that can tell who’s at risk for serious behavioral health disorders, who’s currently being treated for them, and what actually works. The problem is how health plans are looking at all that data.
Is Your Practice’s Payment System Holding You Back? Ask These 3 Key Questions
Efficient payment processing plays a central role in the success of healthcare practices, shaping everything from staff productivity and cash flow to patient satisfaction.
From Plateau to Progress: Unleashing Growth in GI Practices Through Innovation and Alignment
In today’s environment, standing still is the riskiest strategy of all. But to move from plateau to progress, GI practices must redefine what growth looks like.
Pledging ‘Radical Transparency,’ FDA Reveals Drug Rejection Letters — With Limits
The FDA published more than 200 complete response letters, the first step in what it describes as part of its effort to modernize the agency and improve transparency. But there are some caveats to the release of the FDA correspondence.